Flexible and Expedited Regulatory Review Processes for Innovative Medicines and Regenerative Medical Products in the US, the EU, and Japan

Several expedited regulatory review projects for innovative drugs and regenerative medical products have been developed in the US, the EU, and Japan. Each regulatory agency has elaborated an original regulatory framework and adopted regulatory projects developed by the other regulatory agencies. For...

Descripción completa

Detalles Bibliográficos
Autor principal: Nagai, Sumimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696404/
https://www.ncbi.nlm.nih.gov/pubmed/31382625
http://dx.doi.org/10.3390/ijms20153801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696404/
https://www.ncbi.nlm.nih.gov/pubmed/31382625
http://dx.doi.org/10.3390/ijms20153801

Ejemplares similares